Ceritinib Alone for Crizotinib-naive Versus Crizotinib-pretreated for Management of Anaplastic Lymphoma Kinase-rearrangement Non–Small-cell Lung Cancer: A Systematic Review

2018 ◽  
Vol 19 (6) ◽  
pp. e945-e956
Author(s):  
Xuewei Zhao ◽  
Zhangying Feng ◽  
Guanqi Wang ◽  
Haiying Pang ◽  
Mingxia Wang
Sign in / Sign up

Export Citation Format

Share Document